James Hardie stock downgraded by CLSA on weak performance and guidance

Published 22/08/2025, 11:32
James Hardie stock downgraded by CLSA on weak performance and guidance

Investing.com - CLSA downgraded James Hardie Industries (NYSE:JHX) (JHX:AU) from Hold to Underperform and slashed its price target to AUD26.00 from AUD39.50 following disappointing quarterly results. The stock, currently trading at $19.78, has fallen over 31% in the past week, with InvestingPro data showing seven analysts revising earnings expectations downward.

The building materials company reported weaker-than-expected first-quarter fiscal 2026 performance and provided soft guidance for the full year, triggering a sharp sell-off in its shares, according to CLSA.

The research firm noted that initial optimism surrounding James Hardie’s recent merger with Azek has quickly dissipated just one month after the transaction’s completion.

CLSA cited customer destocking due to high new home inventories as a significant demand headwind for the company, suggesting this trend might persist despite potential upcoming interest rate cuts.

The downgrade also reflected concerns about James Hardie’s growth prospects, with CLSA pointing out that key competitors have continued to outperform the company, implying market share losses.

In other recent news, James Hardie Industries reported a 29% decline in its first-quarter underlying net profit after tax compared to the previous year, missing consensus forecasts by 19%. This has led to several analysts adjusting their outlook on the company. UBS downgraded the stock from Buy to Neutral, citing the slump in North American volumes and reduced its price target significantly to AUD36.00. Meanwhile, Morgan Stanley (NYSE:MS) maintained its Overweight rating but lowered its earnings per share estimates by 19-43% for fiscal years 2026-2028, aligning with the company’s FY26 guidance.

BofA Securities also revised its price target downward to $23.70 from $32.80, following a 20% reduction in its FY26 EBITDA forecast. Truist Securities cut its price target to $25.00, maintaining a Buy rating despite weak demand in North America. Jefferies followed suit by lowering its price target to $30.00, describing the company’s fiscal 2025 first-quarter results and guidance as softer and weaker than expected. These developments reflect a cautious outlook among analysts due to the company’s recent performance and guidance.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.